Roche has launched its DISCOVERY 5-Plex procedure and reagents to be used for immunohistochemistry (IHC) research applications.

The pre-optimised, fully automated multiplex procedure is applicable on the VENTANA DISCOVERY ULTRA2 instrument.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Roche's DISCOVERY product line is a research-use-only (RUO) portfolio of instruments and reagents for research in immunohistochemistry (IHC) and in situ hybridisation (ISH).

"The ready-to-use detection reagents offers crisp, specific signals and distinct information about protein co-expression patterns."

A part of the Discovery product portfolio, the DISCOVERY ULTRA research instrument is designed to fully automate single or multiplex IHC and ISH applications and a growing line of reagents for full automation designed to meet the needs of the research community.

The DISCOVERY 5-Plex procedure enables the researchers to investigate up to five biomarkers on a single slide, preserving tissue and maximising data.

See Also:

It facilitates the researchers with a pre-optimised workflow to simplify the staining process. The ready-to-use detection reagents offers crisp, specific signals and distinct information about protein co-expression patterns.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Roche Tissue Diagnostics head Ann Costello said: "To better investigate the complexities of cancer biology and possible treatment strategies, it is increasingly important to detect multiple biomarkers on a single slide.

"The launch of the innovative DISCOVERY 5-Plex procedure advances automation in multiplexing technology, which is expected to play a critical role in cancer research in the future."

The launch of the DISCOVERY 5-Plex procedure will be followed by the commercial launch of the DISCOVERY FAM Kit, DISCOVERY Rhodamine 6G Kit, DISCOVERY Red 610 Kit, and DISCOVERY DCC Kit.